ACA DU PONT METHOTREXATE (MTHO) METHOD

Enzyme Immunoassay, Methotrexate

E.I. DUPONT DE NEMOURS & CO., INC.

The following data is part of a premarket notification filed by E.i. Dupont De Nemours & Co., Inc. with the FDA for Aca Du Pont Methotrexate (mtho) Method.

Pre-market Notification Details

Device IDK884744
510k NumberK884744
Device Name:ACA DU PONT METHOTREXATE (MTHO) METHOD
ClassificationEnzyme Immunoassay, Methotrexate
Applicant E.I. DUPONT DE NEMOURS & CO., INC. DU PONT-BMP22/1152 Wilmington,  DE  19880
ContactChristopher Bentsen
CorrespondentChristopher Bentsen
E.I. DUPONT DE NEMOURS & CO., INC. DU PONT-BMP22/1152 Wilmington,  DE  19880
Product CodeLAO  
CFR Regulation Number510(k) Premarket Notification [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1988-11-14
Decision Date1989-01-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.